Keeney Adam (CIK 1973607) reported 8 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-10). Recent activity: Buy BIIB (1,802 shares), Sell BIIB (589 shares), Buy BIIB (3,278 shares), Sell BIIB (994 shares), Buy BIIB (938 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-10 | BIOGEN INC. (BIIB) | Head of Corporate Development | Buy | 1,802 | $0 |
| 2026-02-10 | BIOGEN INC. (BIIB) | Head of Corporate Development | Sell | 589 | $118,495 |
| 2026-02-10 | BIOGEN INC. (BIIB) | Head of Corporate Development | Buy | 3,278 | $0 |
| 2026-02-10 | BIOGEN INC. (BIIB) | Head of Corporate Development | Sell | 994 | $199,973 |
| 2025-05-05 | BIOGEN INC. (BIIB) | Head of Corporate Development | Buy | 938 | $0 |
| 2025-05-05 | BIOGEN INC. (BIIB) | Head of Corporate Development | Sell | 454 | $54,902 |
| 2025-02-10 | BIOGEN INC. (BIIB) | Head of Corporate Development | Buy | 1,801 | $0 |
| 2025-02-10 | BIOGEN INC. (BIIB) | Head of Corporate Development | Sell | 563 | $79,580 |
Source: SEC Form 4 filings · as of 2026-02-10